Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2023 Mar 13;32(1):16–26. doi: 10.1037/pha0000644

Table 2.

Feasibility and Acceptability Outcomes

Study I (Savor) Study II (RET)
Feasibility
Responded to advertisements (N) 416 453
Eligible and interested (n, %) 99 (23.8%) 119 (26.3%)
 Consented (n, % eligible, interested) 44 (44.4%) 54 (45.4%)
Completed baseline call (enrolled)
Intervention (n)
Control (n)
39 (88.6%)
19
20
40 (74.1%)
25
15
Daily surveys completed (0–28; M, SD) 24.4 (5.41) 23.52 (8.57)
Acceptability
Intervention engagement Days Savored (0–28; M, SD)
Minutes Savored per day (9.7–102.3; M, SD)
Satisfaction (0–10; M, SD)
23.21 (4.43)
29.9 (22.82)
7.77 (1.41)
Watched >90% of either video
   Video 1
   Video 2
   Both
19 (76%)
18 (69%)
15 (57%)
14 (54%)
Patch use days Intervention (0–28; M, SD)
Control (0–28; M, SD)
14.53 (5.37)
9.70 (7.60)
Intervention (0–28; M, SD)
Control (0–28; M, SD)
10.84 (7.44)
3.93 (6.75)

Note: Study II outcomes of daily surveys completed and patch use only include participants who watched at least one video.